Status:
WITHDRAWN
Cryoablation Versus Radiofrequency Ablation for Small Renal Masses
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Conditions:
Renal Cancers
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to verify the oncological efficacy and safety of cryoablation and radiofrequency ablation for the treatment of small renal tumors.
Detailed Description
By enrolling all patients treated with CA or RFA, this study will document for the first time the safety and the short and long term efficacy of CA compared to RFA as well as provide urologists and de...
Eligibility Criteria
Inclusion
- Patients with tumors that progress in size while on a watchful waiting protocol;
- Patients with multiple tumors;
- Patients with a tumor in a solitary kidney;
- Patients with poor renal function and a renal tumor;
- Patients with significant co-morbidities that may benefit from a less invasive approach.
Exclusion
- Large tumors \> 4.0cm;
- Unable to have a general anesthetic;
- Unable to comply with follow-up protocol (i.e., routine CT or MRI and a follow-up biopsy);
- Uncorrectable bleeding diathesis;
- Evidence of metastatic disease.
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00922948
Start Date
March 1 2010
End Date
March 1 2015
Last Update
July 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster Institute of Urology - St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6